Abstract:The Wnt/β - catenin signaling pathway plays numerous essential roles in animal development and tissue/stem cell maintenance. The activation of genes regulated by Wnt/β - catenin signaling requires the nuclear accumulation of β-catenin, a transcriptional co-activator. β-catenin is recruited to many Wnt-regulated enhancers through direct binding to T-cell factor/lymphoid enhancer factor (TCF/LEF) family transcription factors. β-catenin has previously been reported to form phase-separated biomolecular condensates (BMCs), which was implicated as a component of β-catenin's mechanism of action. This function required aromatic amino acid residues in the intrinsically disordered regions (IDRs) at the N- and C-termini of the protein. In this report, we further explore a role for β-catenin BMCs in Wnt target gene regulation. We find that β-catenin BMCs are miscible with LEF1 BMCs in vitro and in cultured cells. We characterized a panel of β-catenin mutants with different combinations of aromatic residue mutations in human cell culture and Drosophila melanogaster . Our data support a model in which aromatic residues across both IDRs contribute to BMC formation and signaling activity. Although different Wnt targets have different sensitivities to loss of β-catenin's aromatic residues, the activation of every target examined was compromised by aromatic substitution. These mutants are not defective in nuclear import or co-immunoprecipitation with several β-catenin binding partners. In addition, residues in the N-terminal IDR with no previously known role in signaling are clearly required for the activation of various Wnt readouts. Consistent with this, deletion of the N-terminal IDR results in a loss of signaling activity, which can be rescued by the addition of heterologous IDRs enriched in aromatic residues. Overall, our work supports a model in which the ability of β-catenin to form biomolecular condensates in the nucleus is tightly linked to its function as a transcriptional co-regulator.

Crystal structure of a β-catenin/Axin complex suggests a mechanism for the β-catenin destruction complex

Crystal Structure of a β-Catenin/Tcf Complex

Phase Separation of Axin Organizes the Β-Catenin Destruction Complex.

Structure of a human Tcf4–β-catenin complex

Molecular regulation and pharmacological targeting of the β-catenin destruction complex

APC Mutations Disrupt Β-Catenin Destruction Complex Condensates Organized by Axin Phase Separation

Crystal Structure of a Full-Length β-Catenin

Liquid–liquid Phase Separation Drives the Β‐catenin Destruction Complex Formation

APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes

Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway

Structural Basis of β-Catenin Recognition by Tax-interacting Protein-1

Structure of a Β-Trcp1-skp1-β-catenin Complex

Analysis of tumor-associated AXIN1 missense mutations identifies variants that activate β-catenin signaling

Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6

Wnt target gene activation requires β-catenin separation into biomolecular condensates

USP10 strikes down β-catenin by dual-wielding deubiquitinase activity and phase separation potential

Roles of Axin in the Wnt Signaling Pathway

Structural basis of beta-catenin recognition by Tax-interacting protein-1.

Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling

The c-Cbl Ubiquitin Ligase Regulates Nuclear β-Catenin and Angiogenesis by Its Tyrosine Phosphorylation Mediated through the Wnt Signaling Pathway*

Inhibition Of Gsk3 Phosphorylation Of Beta-Catenin Via Phosphorylated Pppspxs Motifs Of Wnt Coreceptor Lrp6